Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment
Yanyu Huang, Hsiao-Chi Wang, Junwei Zhao, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1398-1398
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications
Jian-Wen Fang, Yue Lu, Jingyan Zheng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 73
What is new in cancer-associated fibroblast biomarkers?
Zehua Zhao, Tianming Li, Yuan Yuan, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Current approaches in glioblastoma multiforme immunotherapy
Marjan Aghajani, Nazila Jalilzadeh, Ali Aghebati‐Maleki, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1584-1612
Closed Access | Times Cited: 12
Glycosylation in breast cancer progression and mammary development: Molecular connections and malignant transformations
Dongyang Liang, Qian Gao, Zixuan Meng, et al.
Life Sciences (2023) Vol. 326, pp. 121781-121781
Closed Access | Times Cited: 17
The Application of Single-Cell RNA Sequencing in the Inflammatory Tumor Microenvironment
Jiayi Zhao, Yiwei Shi, Guangwen Cao
Biomolecules (2023) Vol. 13, Iss. 2, pp. 344-344
Open Access | Times Cited: 15
Spatial whole transcriptome profiling of primary tumor from patients with metastatic prostate cancer
Paul Vinu Salachan, Martin Rasmussen, Benedicte Parm Ulhøi, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 12, pp. 2055-2067
Open Access | Times Cited: 14
Placental Galectins in Cancer: Why We Should Pay More Attention
Camille Fuselier, Alyssa Dumoulin, Alex Paré, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 437-437
Open Access | Times Cited: 13
Antitumor activity of gamma-irradiated Rosa canina L. against lung carcinoma in rat model: a proposed mechanism
Omayma AR Abo-Zaid, Fatma SM Moawed, Eman Salah Eldin, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access
Smooth Muscle Heterogeneity and Plasticity in Health and Aortic Aneurysmal Disease
Yunwen Hu, Zhaohua Cai, Ben He
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11701-11701
Open Access | Times Cited: 12
PepGAT, a chitinase-derived peptide, alters the proteomic profile of colorectal cancer cells and perturbs pathways involved in cancer survival
Pedro F.N. Souza, Elmer Adilson Espino Zelaya, Emerson Lucena da Silva, et al.
International Journal of Biological Macromolecules (2025) Vol. 299, pp. 140204-140204
Closed Access
Inhibition of Galectin-1 and Androgen Receptor Axis Enhances Enzalutamide Treatment in Enzalutamide Resistant Prostate Cancer
Hsiao-Chi Wang, Allen C. Gao, Roger Xia, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 351-351
Open Access
New perspectives on galectin in major depressive disorder treatment
Laura Cabral Peixoto, Michelle Melgarejo da Rosa
Biochemical Pharmacology (2025) Vol. 233, pp. 116786-116786
Closed Access
Multifaceted roles of Galectins: from carbohydrate binding to targeted cancer therapy
Nan Zhang, Qiao Liu, Dan Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
The sweet and the bitter sides of galectin-1 in immunity: its role in immune cell functions, apoptosis, and immunotherapies for cancer with a focus on T cells
Julianna Novák, T. Takács, Álmos Tilajka, et al.
Seminars in Immunopathology (2025) Vol. 47, Iss. 1
Open Access
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma
Angelica Pace, Fabio Scirocchi, Chiara Napoletano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6312-6312
Open Access | Times Cited: 16
Galectin inhibitors and nanoparticles as a novel therapeutic strategy for glioblastoma multiforme
Willie Elliott
American Journal of Cancer Research (2024) Vol. 14, Iss. 2, pp. 774-795
Open Access | Times Cited: 3
Improving cancer immunotherapy in prostate cancer by modulating T cell function through targeting the galectin-1
Hsiao‐Chi Wang, Roger Xia, Wen‐Hsin Chang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Effect of galectin‐1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma
Jiajun Wang, Sihong Zhang, Ying Wang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 2
Ganoderic acid T, a Ganoderma triterpenoid, modulates the tumor microenvironment and enhances the chemotherapy and immunotherapy efficacy through downregulating galectin-1 levels
Suyu Chen, Kuang-Dee Chen, Yihsiu Lin, et al.
Toxicology and Applied Pharmacology (2024) Vol. 491, pp. 117069-117069
Closed Access | Times Cited: 2
Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
Guillermo A. Videla-Richardson, Olivia Morris-Hanon, Nicolás I. Torres, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 316-316
Open Access | Times Cited: 16
Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities
Ana Bogut, Bojan Stojanović, Marina Jovanović, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15500-15500
Open Access | Times Cited: 6
A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer
Blendi Ura, Valeria Capaci, Michelangelo Aloisio, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1857-1857
Open Access | Times Cited: 10
Development of a cell adhesion-based prognostic model for multiple myeloma: Insights into chemotherapy response and potential reversal of adhesion effects
Qian Hu, Mengyao Wang, J. Wang, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 4, pp. 753-768
Open Access | Times Cited: 1
A Quantitative Human Red Blood Cell Agglutination Assay for Characterisation of Galectin Inhibitors
Rhianna Gasson, James A. Roper, Robert J. Slack
(2024)
Open Access | Times Cited: 1
Non-carbohydrate Galectin-1 inhibitors as promising anticancer agents: Design strategies, structure activity relationship and mechanistic insights
Sridhar Goud Nerella
European Journal of Medicinal Chemistry Reports (2024) Vol. 11, pp. 100170-100170
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top